Affiliation:
1. The Danish National Research Foundation and Villum Foundation’s Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics, Department of Health Technology, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
Abstract
Ingestible self-configurable proximity-enabling devices have been developed as a non-invasive platform to improve the bioavailability of drug compounds via swellable or self-unfolding devices. Self-unfolding foils support unidirectional drug release in close proximity to the intestinal epithelium, the main drug absorption site following oral administration. The foils are loaded with a solid-state formulation containing the active pharmaceutical ingredient and then coated and rolled into enteric capsules. The coated lid must remain intact to ensure drug protection in the rolled state until targeted release in the small intestine after capsule disintegration. Despite promising results in previous studies, the deposition of an enteric top coating that remains intact after rolling is still challenging. In this study, we compare different mixtures of enteric polymers and a plasticizer, PEG 6000, as potential coating materials. We evaluate mechanical properties as well as drug protection and targeted release in gastric and intestinal media, respectively. Commercially available Eudragit® FL30D-55 appears to be the most suitable material due to its high strain at failure and integrity after capsule fitting. In vitro studies of coated foils in gastric and intestinal media confirm successful pH-triggered drug release. This indicates the potential advantage of the selected material in the development of self-unfolding foils for oral drug delivery.
Funder
Novo Nordisk Foundation
European Research Council
Danish National Research Foundation
Villum Fonden
Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics
Reference49 articles.
1. Physical Methods for Enhancing Drug Absorption from the Gastrointestinal Tract;Luo;Adv. Drug Deliv. Rev.,2021
2. Absorption Sites of Orally Administered Drugs in the Small Intestine;Murakami;Expert Opin. Drug Discov.,2017
3. Strategies and Industrial Perspectives to Improve Oral Absorption of Biological Macromolecules;Liu;Expert Opin. Drug Deliv.,2017
4. Toward Oral Delivery of Biopharmaceuticals: An Assessment of the Gastrointestinal Stability of 17 Peptide Drugs;Wang;Mol. Pharm.,2015
5. Wang, J., Chen, Y., Han, L., Xia, S., Zhang, X., Xue, P., Kang, Y., Ming, J., and Xu, Z. (2023). Microenvironment Responsive Pod-Structured Astaxanthin Nanocarrier for Ameliorating Inflammatory Bowel Disease. Chin. Chem. Lett., 109029.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献